antofloxacin

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2018
02420072018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Aim:To find an appropriate dose regimen of the novel antibacterial agent antofloxacin for a phase II clinical trial using a… (More)
  • table 2
  • table 1
  • figure 1
  • table 3
  • figure 3
Is this relevant?
2011
2011
Aim:To evaluate the pharmacokinetic interactions between theophylline and antofloxacin in vivo and in vitro.Methods:A randomized… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2011
2011
BACKGROUND A new fluroquinolone antibacterial agent, antofloxacin hydrochloride, developed in China, is an 8-NH(2) derivant of… (More)
Is this relevant?
2011
2011
The purpose of the study was to evaluate pharmacokinetic characteristics of antofloxacin hydrochloride, a new fluoroquinolone… (More)
Is this relevant?
2011
2011
Clinical studies have revealed that some fluoroquinolones may cause severe adverse effects when co-administered with substrates… (More)
Is this relevant?
2010
2010
AIMS To evaluate the clinical and bacterial efficacies and the safety of antofloxacin hydrochloride tablets in the treatment of… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2009
2009
A recent focus was to investigate whether antofloxacin, an 8-NH(2) derivative of levofloxacin, inhibited cytochrome P450 (CYP… (More)
Is this relevant?
2008
2008
OBJECTIVE To evaluate the tolerability and pharmacokinetics characteristics of antofloxacin hydrochloride, a fluoroquinolone… (More)
Is this relevant?
2008
2008
Antofloxacin hydrochloride is a newly developed fluoroquinolone antibacterial in China, which has comparable in vitro and animal… (More)
Is this relevant?
2008
2008
Our aim was to investigate whether renal impairment induced by cisplatin altered the pharmacokinetics of antofloxacin… (More)
Is this relevant?